Transverse vaginal septum corresponds to which anatomical structure?
An ovarian cyst is detected in a pregnant woman; what is the recommended management?
What is the most valuable diagnostic test in a case of suspected ectopic pregnancy?
After treatment of ectopic pregnancy with methotrexate, at what intervals are hCG levels typically checked?
What is the most common presenting feature of Asherman's syndrome?
Maximum chances of ureteric injury are associated with which gynecological procedure?
The provided Hysterosalpingogram image demonstrates which of the following uterine anomalies?

What are the diagnostic criteria for ovarian pregnancy?
Which location of ectopic pregnancy is associated with the longest duration before diagnosis?
A patient presents with postmenopausal bleeding. Endometrial biopsy should be performed if the endometrial thickness is more than:
Explanation: **Explanation:** The **transverse vaginal septum** is a rare Mullerian duct anomaly resulting from a failure of fusion or canalization between the **Mullerian ducts** (which form the upper 4/5th of the vagina) and the **urogenital sinus** (which forms the lower 1/5th of the vagina). 1. **Why External Os is Correct:** Anatomically, the most common site for a transverse vaginal septum is at the junction of the upper and middle third of the vagina. In a normal pelvic orientation, this level corresponds horizontally to the level of the **external os** of the cervix. It represents the point where the downward-growing paramesonephric ducts meet the upward-growing sinovaginal bulbs. 2. **Why Incorrect Options are Wrong:** * **Vesical neck & Bladder base:** These are anterior structures related to the anterior vaginal wall and the vesicovaginal septum, but they do not serve as the anatomical landmark for the transverse septum's horizontal plane. * **Hymen:** The hymen is located at the vaginal introitus (the junction of the urogenital sinus and the exterior). An **imperforate hymen** is a distinct clinical entity from a transverse vaginal septum, though both cause primary amenorrhea and hematocolpos. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Primary amenorrhea with cyclic pelvic pain. * **Physical Exam:** Unlike an imperforate hymen (which shows a bulging, bluish membrane at the introitus), a transverse septum is located higher up; the hymen appears normal on inspection. * **MRI/USG:** Essential to differentiate the thickness of the septum and its distance from the cervix for surgical planning (Sears’ procedure). * **Mnemonic:** "Mullerian = Middle/Upper" (Septum is usually high), "Urogenital = Under" (Hymen is at the bottom).
Explanation: ### Explanation The management of an ovarian cyst during pregnancy depends on the gestational age and the risk of complications like torsion, rupture, or malignancy. **Why Option C is Correct:** The **second trimester (specifically 14–18 weeks)** is the "surgical window of safety." By this time, the placenta has taken over progesterone production from the corpus luteum, significantly reducing the risk of miscarriage following adnexal surgery. Additionally, the uterus is not yet large enough to obstruct the surgical field, and the risk of preterm labor is lower compared to the third trimester. **Analysis of Incorrect Options:** * **A. Immediate removal by laparotomy:** If performed in the first trimester, there is a high risk of removing the corpus luteum (essential for pregnancy maintenance) and a higher risk of miscarriage due to uterine irritability. * **B. Wait and watch:** While small, simple cysts (<5–6 cm) often resolve spontaneously, persistent or large cysts carry a 10–15% risk of **torsion**, especially during uterine involution or ascent. Therefore, symptomatic or large persistent cysts require intervention. * **D. Removal at the time of cesarean section:** Waiting until delivery increases the risk of emergency complications (torsion/rupture) throughout the pregnancy. Furthermore, a C-section is not always indicated for an ovarian cyst. **High-Yield Clinical Pearls for NEET-PG:** * **Most common ovarian cyst in pregnancy:** Corpus luteum cyst (usually regresses by 12–14 weeks). * **Most common benign tumor in pregnancy:** Mature cystic teratoma (Dermoid cyst). * **Most common complication:** Torsion (most frequent in the 2nd trimester or early puerperium). * **Indications for surgery:** Cyst >6–8 cm, solid components on ultrasound, or features suggestive of torsion/malignancy. * **Laparoscopy vs. Laparotomy:** While the option says laparotomy, modern guidelines suggest laparoscopy is safe and often preferred in the second trimester when performed by experts.
Explanation: **Explanation:** The diagnosis of ectopic pregnancy relies on the "Discriminatory Zone" concept—the level of serum beta-hCG at which an intrauterine pregnancy (IUP) should be visible. **1. Why Transvaginal Ultrasound (TVS) is the correct answer:** TVS is the **most valuable diagnostic tool** because it provides direct anatomical evidence. It can confirm an IUP (ruling out ectopic via the principle of exclusivity, except in rare heterotopic cases) or visualize an adnexal mass/gestational sac. TVS is superior to transabdominal ultrasound as it can detect an IUP at lower hCG levels (1,500–2,000 mIU/mL). Finding an empty uterus with an adnexal mass in a patient with a positive pregnancy test is highly diagnostic. **2. Why other options are incorrect:** * **Serial beta-hCG levels:** While crucial for monitoring viability and determining the discriminatory zone, a single or serial level cannot pinpoint the *location* of the pregnancy. It is a supportive biochemical test, not a definitive diagnostic one. * **Progesterone measurement:** Levels <5 ng/mL suggest a non-viable pregnancy but do not distinguish between a miscarriage and an ectopic pregnancy. It is rarely used in modern clinical practice. * **Culdocentesis:** Historically used to detect hemoperitoneum (ruptured ectopic), it has been largely replaced by the non-invasive and more accurate TVS. **Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Laparoscopy (allows for both diagnosis and immediate surgical management). * **Most common site:** Ampulla of the Fallopian tube. * **Arias-Stella Reaction:** Hypersecretory endometrium seen on biopsy; it is suggestive of pregnancy but not specific to ectopic. * **Classic Triad:** Amenorrhea, abdominal pain, and vaginal bleeding (present in only 50% of cases).
Explanation: **Explanation:** The medical management of ectopic pregnancy primarily utilizes **Methotrexate (MTX)**, a folic acid antagonist that inhibits DNA synthesis in rapidly dividing trophoblastic cells. According to standard protocols (ACOG and RCOG), the success of treatment is monitored by serial serum β-hCG measurements. **Why Day 4 and Day 7?** After the administration of MTX (Day 0), it is common for β-hCG levels to **increase** during the first few days due to the continued release of hCG from the lysing trophoblastic tissue. Therefore, the first post-treatment check is done on **Day 4** to establish a baseline peak. The second check is on **Day 7**. * **The Criterion for Success:** A decline of **≥15%** in β-hCG levels between Day 4 and Day 7 indicates successful treatment. If the decline is <15%, a second dose of MTX or surgical intervention is considered. **Analysis of Incorrect Options:** * **Day 0 and Day 4:** Day 0 is the day of administration; while a baseline is taken then, the critical assessment of drug efficacy requires the Day 7 comparison. * **Day 1 and Day 4/7:** Day 1 is too early to observe the biochemical shift required to predict treatment success. **High-Yield Clinical Pearls for NEET-PG:** * **Indications for MTX:** Hemodynamically stable patient, β-hCG <5000 mIU/mL, no fetal cardiac activity, and an adnexal mass <3.5–4 cm. * **Follow-up:** After the initial 15% drop, β-hCG should be monitored **weekly** until it reaches non-pregnant levels (<5 mIU/mL). * **Patient Counseling:** Advise patients to avoid folic acid supplements, NSAIDs (risk of masking rupture pain), and sunlight (MTX photosensitivity) during treatment.
Explanation: **Explanation:** **Asherman’s Syndrome** is characterized by the formation of intrauterine adhesions (synechiae) following trauma to the basal layer of the endometrium, most commonly due to over-zealous curettage (D&C) after a miscarriage or delivery. **Why Hypomenorrhea is the correct answer:** The primary pathology is the replacement of functional endometrial tissue with fibrous adhesions. This reduction in the total surface area of the functional endometrium leads to a proportional decrease in menstrual blood flow. While secondary amenorrhea can occur in severe cases where the uterine cavity is completely obliterated, **hypomenorrhea** (scanty menses) is statistically the most common presenting symptom as many patients retain small islands of functional tissue. **Analysis of Incorrect Options:** * **Oligomenorrhea:** This refers to infrequent cycles (>35 days). In Asherman’s, the hypothalamic-pituitary-ovarian axis remains intact; therefore, the cycle frequency is usually normal, but the flow is reduced. * **Menometrorrhagia:** This involves heavy and irregular bleeding. Asherman’s syndrome causes a *reduction* in flow, making this the clinical opposite of the expected presentation. * **Dysmenorrhea:** While some patients experience cyclic pelvic pain if blood gets trapped behind adhesions (hematometra), it is a secondary symptom and far less common than flow disturbances. **NEET-PG High-Yield Pearls:** * **Gold Standard Investigation:** Hysteroscopy (both diagnostic and therapeutic). * **Hysterosalpingography (HSG) finding:** Characteristic "filling defects" or a "honeycomb appearance." * **Treatment:** Hysteroscopic adhesiolysis followed by an intrauterine device (IUD) or Foley catheter and high-dose estrogen to promote endometrial regrowth. * **Most common cause:** Post-partum or post-abortal curettage (trauma + infection).
Explanation: **Explanation:** **Wertheim’s Hysterectomy (Radical Hysterectomy)** is associated with the highest risk of ureteric injury among gynecological procedures. This is primarily due to the extensive dissection required to treat cervical cancer. The procedure involves the wide excision of the parametrium and the mobilization of the ureter from the "ureteric tunnel" (under the uterine artery) to ensure adequate surgical margins and lymphadenectomy. This extensive skeletonization increases the risk of direct surgical trauma (crushing or transection) and devascularization, leading to postoperative fistulas. **Analysis of Incorrect Options:** * **Total Abdominal Hysterectomy (TAH):** While TAH is the most common procedure where ureteric injuries occur in absolute numbers (due to the high volume of surgeries performed), the *relative risk* per procedure is significantly lower than in radical surgery. * **Vaginal Hysterectomy:** The risk is lower here as the ureters are naturally displaced laterally and superiorly when the uterus is pulled down, provided there is no significant pelvic organ prolapse or distorted anatomy. * **Anterior Colporrhaphy:** This procedure involves the vaginal wall and bladder base; while the bladder is at risk, the ureters are generally distant from the primary site of dissection. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site of injury:** At the level of the **ischial spine** (where the ureter passes under the uterine artery—"Water under the bridge"). * **Second most common site:** The pelvic brim, during ligation of the infundibulopelvic ligament. * **Most common cause of ureteric injury overall:** Total Abdominal Hysterectomy (due to frequency). * **Highest risk per procedure:** Wertheim’s Hysterectomy. * **Gold standard for diagnosis:** Intravenous Pyelogram (IVP) or CT Urography.
Explanation: ***Uterine didelphys*** - Shows **two completely separate uterine cavities** with **no communication** between them on HSG, representing complete failure of Müllerian duct fusion. - Associated with **duplicate cervices** and often **longitudinal vaginal septum**, making it the most severe form of **uterine duplication anomaly**. *Septate uterus* - HSG would show a **single external uterine contour** with **internal division** by a septum, not two separate cavities. - The **fundal contour remains normal** externally, distinguishing it from bicornuate or didelphys variants. *Bicornuate uterus* - Demonstrates **two uterine horns** that **communicate at the cervix** with a **heart-shaped external fundal contour**. - HSG shows **partial separation** of cavities that **converge toward the cervix**, unlike the complete separation in didelphys. *Arcuate uterus* - Shows only a **mild indentation** of the **fundal contour** with minimal impact on the uterine cavity shape. - HSG reveals a **near-normal cavity** with slight **fundal flattening**, representing the mildest Müllerian anomaly.
Explanation: **Explanation:** **1. Why Spiegelberg Criteria is Correct:** Ovarian pregnancy is a rare form of ectopic pregnancy where the gestational sac is implanted within the ovary. To distinguish a primary ovarian pregnancy from a tubal pregnancy that has secondarily involved the ovary, the **Spiegelberg criteria (1878)** are used. The four mandatory requirements are: * The fallopian tube on the affected side must be intact and separate from the ovary. * The gestational sac must occupy the normal position of the ovary. * The sac must be connected to the uterus by the ovarian ligament. * Histological proof of ovarian tissue must be present in the wall of the gestational sac. **2. Analysis of Incorrect Options:** * **Studiford Criteria:** These are the diagnostic criteria for **Primary Abdominal Pregnancy**. They require normal tubes/ovaries and no evidence of a recent pregnancy in the uterus. * **Rubin’s Criteria:** Used to determine the patency of fallopian tubes via **Insufflation tests** (historical context) or to define criteria for **Cervical Pregnancy**. * **Timor-Tritsch Criteria:** These are sonographic criteria used for the diagnosis of **Cesarean Scar Pregnancy (CSP)**. **3. NEET-PG High-Yield Pearls:** * **Most common site of ectopic pregnancy:** Ampulla of the Fallopian tube. * **Risk factors for Ovarian Pregnancy:** Unlike tubal pregnancy, ovarian pregnancy is **not** strongly associated with PID. It is more frequently associated with **IUD use**. * **Management:** Usually surgical (wedge resection or cystectomy) to preserve ovarian tissue. * **Gold Standard for Diagnosis:** Histopathology (demonstrating chorionic villi within ovarian stroma).
Explanation: **Explanation:** The **interstitial (cornual)** portion of the fallopian tube is the segment that traverses the thick muscular wall of the uterus (myometrium). Because this area is surrounded by distensible myometrium rather than just the thin tubal wall, it can accommodate a growing gestational sac for a much longer period (up to **12–16 weeks**) before rupture occurs. Consequently, these pregnancies remain asymptomatic longer, leading to a delayed diagnosis compared to other tubal sites. **Analysis of Options:** * **A. Interstitial (Correct):** The rich vascularity (from both uterine and ovarian arteries) and myometrial support allow the pregnancy to grow larger. However, when it does rupture, it often results in catastrophic, life-threatening hemorrhage. * **B & D. Ampullary:** The ampulla is the most common site of ectopic pregnancy (70–80%). Because the lumen is wider than the isthmus but lacks myometrial support, it typically ruptures or presents between **8–10 weeks**. * **C. Isthmic:** The isthmus is the narrowest part of the tube. Due to the lack of distensibility, isthmic pregnancies present the earliest, usually rupturing between **6–8 weeks**. **NEET-PG High-Yield Pearls:** * **Most common site overall:** Ampulla. * **Most common site for rupture:** Isthmus (earliest rupture). * **Most dangerous site:** Interstitial (highest risk of massive hemorrhage/shock). * **Baartman’s Sign:** A clinical sign where the uterus feels asymmetrical due to an interstitial pregnancy. * **Ultrasonography:** Look for the "interstitial line sign" (an echogenic line extending from the endometrial canal to the center of the ectopic mass).
Explanation: **Explanation:** In a postmenopausal woman presenting with vaginal bleeding, the primary goal is to rule out **endometrial carcinoma**. Transvaginal Ultrasound (TVUS) is the initial screening tool used to measure endometrial thickness (ET). **1. Why 5 mm is the correct answer:** Clinical guidelines (ACOG and RCOG) establish that an endometrial thickness of **<4 mm** in a postmenopausal woman has a high negative predictive value (over 99%) for endometrial cancer. Therefore, if the ET is **≥4 mm or 5 mm** (depending on the specific protocol used in various textbooks), an endometrial biopsy is mandatory to obtain a tissue diagnosis. In the context of NEET-PG and standard Indian medical curricula (Dutta/Shaw), **5 mm** is the widely accepted threshold for intervention in symptomatic patients. **2. Analysis of Incorrect Options:** * **A (3 mm):** This is considered normal for a postmenopausal woman. Biopsy at this stage would lead to unnecessary invasive procedures with very low diagnostic yield. * **C & D (7 mm or 8 mm):** These values are significantly elevated. While a biopsy is definitely required at these thicknesses, they are not the *minimum* threshold. Waiting for the endometrium to reach 7-8 mm would delay the diagnosis of early-stage malignancy. **3. NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** Dilation and Curettage (D&C) or Hysteroscopic-guided biopsy is the gold standard, though Pipelle biopsy is the initial office procedure of choice. * **Asymptomatic Patients:** If a postmenopausal woman has **no bleeding** but an incidental finding of thickened endometrium, the threshold for biopsy is usually higher (**>8-11 mm**). * **Tamoxifen Users:** Patients on Tamoxifen often have a "false" thickening of the endometrium due to subepithelial stromal hypertrophy; however, any bleeding in these patients must be investigated regardless of thickness. * **Most common cause** of postmenopausal bleeding is **Atrophic Vaginitis/Endometritis**, but the most important to rule out is **Malignancy**.
Abnormal Uterine Bleeding
Practice Questions
Endometriosis
Practice Questions
Adenomyosis
Practice Questions
Uterine Fibroids
Practice Questions
Ovarian Cysts
Practice Questions
Pelvic Inflammatory Disease
Practice Questions
Vulvovaginitis
Practice Questions
Pelvic Organ Prolapse
Practice Questions
Vulvar Disorders
Practice Questions
Benign Breast Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free